<DOC>
	<DOCNO>NCT00018382</DOCNO>
	<brief_summary>This study examine use insulin-sensitizing compound , therapeutic agent cognitive impairment Alzheimer 's disease .</brief_summary>
	<brief_title>Insulin , Neurogenetics Memory Alzheimer 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Rosiglitazone</mesh_term>
	<criteria>Men woman mild Alzheimer 's Disease without serious medical psychiatric comorbid condition .</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2004</verification_date>
</DOC>